Form 4: Rallybio Corp Director Hopfner Acquires Options
SEC Form 4 Filing
Director Robert Lorne Hopfner acquired options to purchase 16,500 shares of Rallybio Corp common stock on May 15, 2024.
Summary
- Robert Lorne Hopfner, a director of Rallybio Corp, filed a Form 4 on May 17, 2024, reporting a transaction.
- On May 15, 2024, Hopfner acquired options to purchase 16,500 shares of Rallybio Corp common stock at an exercise price of $1.91.
- The options vest on the earlier of May 15, 2025, or the date of the company's 2025 Annual Meeting of Stockholders.
- Following the transaction, Hopfner directly owns options for 16,500 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it simply reports the granting of options to a director, which is a common practice.
Positives
- The granting of options to a director aligns their interests with those of the shareholders.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Stakeholder Impact
- The granting of options to a director can align their interests with those of shareholders, potentially leading to increased company value.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of option grant |
| 05/15/2024 | Earliest transaction date |
| 05/17/2024 | Date of Form 4 filing |
| 05/15/2025 | Option vesting date (earlier of this date or the 2025 Annual Meeting of Stockholders) |
| 05/15/2034 | Option expiration date |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.